PATHOMORPHOLOGICAL AND CLINICAL CHARACTERISTICS OF BREAST CANCER IN MEN IN THE REPUBLIC OF UZBEKISTAN

Authors

  • Uktam M. Kurbankulov Senior Lecturer of the Department of Oncology Tashkent Medical Academy. Tashkent, Uzbekistan
  • Munira X. Norbekova Assistant of the Department of Oncology Tashkent Medical Academy. Tashkent, Uzbekistan

Keywords:

Breast cancer in men, pathogenetic mechanism, detection in the Republic of Uzbekistan

Abstract

Oncological diseases remain a pressing problem in the world. In recent years, according to official world medical statistics, the incidence of cancer has been increasing worldwide. According to statistics from the World Health Organization (WHO), “by 2030, there will be 15 million people in the world with dangerous diseases, so the system for predicting early diagnosis, as well as surgical treatment and systemic treatment of oncological diseases has not yet been clarified.” WHO notes an annual increase in breast cancer diagnosed in women, but detection of a similar cancer in men is very rare and accounts for 1% of the total number of detected cases, while this disease accounts for about 0.2. Scientific research on male breast cancer is being conducted all over the world, but there are few of them, in this regard, our research helps fill the gap in the assessment and scientific study of this oncological pathology in men, and there are also unique scientific studies devoted to the early diagnosis and prognosis of male breast cancer . Therefore, the pathomorphological and molecular genetic characteristics of breast cancer in men is one of the most important problems of fundamental medicine and oncology.

References

Volchenko A.A., Pak D.D., Usov F.N., Fetisova E.Yu. Giant leaf-shaped tumor of the mammary gland: clinical observation // Tumors of the female reproductive system. 2017. N 2. P. 27-29.

Dmitriev V.N. A comprehensive study of morbidity, mortality and disability due to malignant neoplasms of the female genital organs and PGTT for improving medical and social examination and rehabilitation: abstract of thesis. dis. ... doc. honey. Sci. Moscow, 2015. 337 p.

Zavyalova M.V. The relationship between the morphological phenotype of the tumor, lymphogenous and hematogenous metastasis in infiltrating ductal breast cancer: abstract. dis. ... doc. honey. Sci. Tomsk, 2019. 44 p.

Malignant neoplasms in Russia in 2016 (morbidity and mortality) // ed. HELL. Kaprina, V.V. Starinsky, G.V. Petrova. M.: MNIOI im. P.A. Herzen - branch of the Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of Russia, 2018. 250 p.

Imyanitov E.N. General ideas about targeted therapy // Practical Oncology. 2020. T. 11, N 3. P. 123-130.

Kolyadina I.V., Poddubnaya I.V., Frank G.A. and others. Heterogeneity of stage I breast cancer: biological and prognostic significance // Malignant tumors. 2015. N 1. P. 35-45.

Kuligina E.Sh. Epidemiological and molecular aspects of breast cancer // Practical Oncology. 2020. T. 11, N 4. P. 203216.

Mayborodin I.V., Krasilnikov S.E., Kozyakov A.E. and others. The feasibility of studying tumor angiogenesis as a prognostic factor for cancer development // News of surgery. 2015. T. 23, N. 3. pp. 339 - 347.

Odintsova I.N. Epidemiology of breast cancer in the region of Siberia and the Far East: abstract. dis. ...doc. honey. Sci. Tomsk, 2021. 42 p.

Semiglazov V.F., Semiglazov V.V., Manikhas A.G. and others. Individualization of adjuvant therapy for breast cancer // Farmateka 2021. N 7. P. 8-13.

Snegovoi A.V., Manzyuk L.V. The importance of biomarkers for determining treatment tactics and prognosis // Practical Oncology. 2021. T. 12, N 4. pp. 166-170.

The state of cancer care for the population of Russia in 2016 / Ed. HELL. Kaprina, V.V. Starinsky, G.V. Petrova. M.: MNIOI im. P.A. Herzen - branch of the Federal State Budgetary Institution "NMRRC" of the Ministry of Health of Russia, 2017. 236 p.

Tsoi L.K. Prognostic significance of clinical, morphological, immunohistochemical factors in patients with stage I and IIa breast cancer: abstract. dis. ...cand. honey. Sci. Moscow, 2021. 144 p.

Aalders K.C., Tryfonidis K., Senkus E. et al. Anti-angiogenic treatment in breast cancer: facts, successes, failures and future perspectives // Cancer Treat Rev. 2017. Vol. 53. P. 98-110.

Acs G., Paragh G., Chuang S.T. et al. The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma // Am J Surg Pathol. 2019. Vol. 33, I. 2. P. 202 - 210.

Acs G., Paragh G., Rakosy Z. et al. The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma // Mod Pathol. 2012. Vol. 25, I. 2. P. 163-77.

Adams S., Gray R., Demaria S. et al. Prognostic value of tumor-infiltrating lymphocytes (TILs) in two phases randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 // J Clin Oncol. 2014. Vol. 32, I. 27. P. 295966.

Ahn K.J., Park J., Choi Y. Lymphovascular invasion as a negative prognostic factor for triple-negative breast cancer after surgery // Radiat Oncol J. 2017. Vol. 35, I. 4. P. 332-339.

Aird W.C. Endothelial cell heterogeneity // Cold Spring Harb Perspect Med. 2012. Vol. 2, I. 1.

Aird W.C. Molecular heterogeneity of endothelium tumor // Cell Tissue Res. 2019. Vol. 335, I. 1. P. 271-81.

Downloads

Published

2023-09-28

How to Cite

Uktam M. Kurbankulov, & Munira X. Norbekova. (2023). PATHOMORPHOLOGICAL AND CLINICAL CHARACTERISTICS OF BREAST CANCER IN MEN IN THE REPUBLIC OF UZBEKISTAN. World Bulletin of Public Health, 26, 47-51. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/3179

Issue

Section

Articles